Enapotamab

Enapotamab (Anti-AXL/UFO Reference Antibody) is an AXL/UFO-related antibody that can be used for synthesis of ADC molecule Enapotamab vedotin (HY-P99921) [1].

Product Specifications

CAS Number

[1912423-61-0]

Product Name Alternative

Anti-AXL/UFO Reference Antibody (enapotamab)

UNSPSC

12352203

Target

ADC Antibody; TAM Receptor

Type

Inhibitory Antibodies

Related Pathways

Antibody-drug Conjugate/ADC Related; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/enapotamab.html

Purity

99.9

Solubility

H2O

Smiles

[Enapotamab]

Molecular Weight

(143.895 kDa)

References & Citations

[1]Matthew T. Burger, et al. Bcl-xl inhibitor antibody-drug conjugates and methods of use thereof. WO2022115477A1.|[2]Koopman LA, et al. Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. JCI Insight. 2019 Nov 1;4 (21) :e128199.